These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1323795)

  • 21. Patient to patient transmission of hepatitis C virus in hemodialysis units.
    Taskapan H; Oymak O; Dogukan A; Utas C
    Clin Nephrol; 2001 Jun; 55(6):477-81. PubMed ID: 11434360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
    Caramelo C; Navas S; Alberola ML; Bermejillo T; Reyero A; Carreño V
    Nephron; 1994; 66(4):470-3. PubMed ID: 7517019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of transmission of hepatitis C by hemodialysis.
    Sungur C; Ozkuyumcu C; Ozen S; Yasavul U; Turgan C; Caglar S
    Nephron; 1993; 64(2):313. PubMed ID: 7686637
    [No Abstract]   [Full Text] [Related]  

  • 24. Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation?
    Harmankaya O; Cetin B; Obek A; Seber E
    Ren Fail; 2002 Sep; 24(5):639-44. PubMed ID: 12380910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence.
    Pujol FH; Ponce JG; Lema MG; Capriles F; Devesa M; Sirit F; Salazar M; Vásquez G; Monsalve F; Blitz-Dorfman L
    J Clin Microbiol; 1996 Jul; 34(7):1633-6. PubMed ID: 8784559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antibodies against hepatitis C virus in a dialysis unit.
    Cantù P; Mangano S; Masini M; Limido A; Crovetti G; DeFilippo C
    Nephron; 1992; 61(3):337-8. PubMed ID: 1323784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus antibody response in acute and chronic non-A, non-B hepatitis.
    Tagger A; Ribero ML; Grossi A; Chiaramonte S; Bortolotti F; Tremolada F
    Nephron; 1992; 61(3):258-9. PubMed ID: 1323766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease.
    Knudsen F; Wantzin P; Rasmussen K; Ladefoged SD; Løkkegaard N; Rasmussen LS; Lassen A; Krogsgaard K
    Kidney Int; 1993 Jun; 43(6):1353-6. PubMed ID: 7686238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relative risk of hepatitis C virus transmission in polytransfused patients].
    Schujman L; Lavitula S; Maris Acebal S; Suita GR; Montero A
    Medicina (B Aires); 1994; 54(3):199-202. PubMed ID: 7854084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies.
    Vasile A; Allegra V; Canciani D; Forchì G; Mengozzi G
    Nephron; 1992; 61(3):318-9. PubMed ID: 1323779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV infections in dialysis patients.
    Scotto G; Savastano AM; Forcella M; Tantimonaco G; Amato G; Salatino G; Pappani A; Stella I
    Nephron; 1992; 61(3):320-1. PubMed ID: 1323780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV seroprevalence in dialysis patients, their relatives and medical staff.
    Capşa D; Cernescu S; Constantinescu SN; Cernescu C
    Rev Roum Virol; 1991; 42(3-4):171-5. PubMed ID: 1667584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: a two year follow-up.
    Jankovic N; Cala S; Nadinić B; Varlaj-Knobloch V; Pavlović D
    Int J Artif Organs; 1994 Mar; 17(3):137-40. PubMed ID: 7519583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.
    Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H
    J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients].
    Motta M; Brischetto R; Rapisarda F; Corno C; Rapisarda C; Fatuzzo P; Messina A; Biondi A; Mezzasalma E; Calcara G
    Ann Ital Med Int; 1991; 6(4):375-8. PubMed ID: 1666516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis.
    Vandelli L; Medici G; Savazzi AM; De Palma M; Vecchi C; Zanchetta G; Lusvarghi E
    Nephron; 1992; 61(3):260-2. PubMed ID: 1323767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients.
    Almroth G; Ekermo B; Franzén L; Hed J
    Nephron; 1991; 59(2):232-5. PubMed ID: 1659671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HCV in a group of chronic hemodialysis patients.
    Scipioni F; Di Filippo L; Maccarone M; Viola D; Ruzzi L; Terlizzi R
    Nephron; 1992; 61(3):362. PubMed ID: 1323791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The low contagiousness of the hepatitis C virus in hemodialysis].
    Robles NR; Gómez Ainsua C; Cruz A
    Rev Clin Esp; 1993 Feb; 192(2):67-9. PubMed ID: 8384726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.